XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

Accrued Liabilities (Notes) | 3 Months Ended
--- | ---
Mar. 31, 2025
Accrued Liabilities [Abstract] |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | Accrued Liabilities and Other Long-Term Liabilities Accrued liabilities consist of the following (in thousands):
| As of
| March 31, 2025 |  | December 31, 2024
Salaries and benefits | $ | 71,756 |  |  | $ | 60,815 |
Incentive compensation | 29,124 |  |  | 59,445 |
Operating lease liability-ST | 13,472 |  |  | 15,695 |
Accrued sales taxes and other taxes | 7,201 |  |  | 9,013 |
Restructuring accrual | 8,522 |  |  | 9,945 |
Deferred revenue | 32,485 |  |  | 30,358 |
Italy medical device payback provision(1) | 25,530 |  |  | 23,937 |
Legal accrual | 3,159 |  |  | 3,425 |
Distribution fees | 14,072 |  |  | 16,548 |
Warranties and returns | 4,070 |  |  | 4,094 |
Field service corrective action(2) | 29,291 |  |  | 32,844 |
Accrued freight | 9,413 |  |  | 13,206 |
Foreign exchange contracts | 4,335 |  |  | 7,391 |
Accrued audit and professional services | 7,579 |  |  | 7,562 |
Defined benefit plan | 4,276 |  |  | 3,111 |
Other | 14,607 |  |  | 9,534 |
| $ | 278,892 |  |  | $ | 306,923 |
___________________________ (1) Related to potential payments associated with the IMDP (as defined below) as a result of 2015 legislation enacted requiring medical device companies to make payments to the Italian government based on regional expenditure ceilings (see Note 20: Commitments and Contingencies for further details). (2) Primarily includes field corrective actions associated with certain products in connection with a 2021 Warning Letter (as defined below) received by Smiths Medical from the FDA following an inspection of Smiths Medical's Oakdale, Minnesota Facility (see Note 20: Commitments and Contingencies for further details). As of March 31, 2025 and December 31, 2024, certain accrued liability account balances that are part of a disposal group that met the criteria for assets held for sale during the fourth quarter of 2024 were presented as a separate line item "Liabilities held for sale" in our consolidated balance sheet (See Note 4:Assets Held For Sale). Other long-term liabilities consist of the following (in thousands):
| As of
| March 31, 2025 |  | December 31, 2024
Operating lease liability-LT | $ | 48,234 |  |  | $ | 40,777 |
Benefits | 3,896 |  |  | 3,830 |
Finance lease liability-LT | 2,342 |  |  | 2,332 |
Deferred revenue | 9,200 |  |  | 9,045 |
Field service corrective action(1) | 8,351 |  |  | 6,401 |
Other | 5,614 |  |  | 4,360 |
| $ | 77,637 |  |  | $ | 66,745 |
______________________________ (1) Primarily related to field service corrective actions associated with certain products in connection with a 2021 Warning Letter (as defined below) received by Smiths Medical from the FDA following an inspection of Smiths Medical’s Oakdale, Minnesota Facility (see Note 20: Commitments and Contingencies for further details).

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(24)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration